Skip to main content

Eun-Sil Shelley Hwang

Mary and Deryl Hart Distinguished Professor of Surgery, in the School of Medicine
Surgical Oncology

Selected Grants


Duke Research Training Program in Surgical Oncology

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2024 - 2029

Advanced Immunobiology Traning Program for Surgeons

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2019 - 2029

IMPROVE DCIS: Identifying Molecular Predictors of Risk to Objectively Validate Evolution of DCIS

ResearchPrincipal Investigator · Awarded by Stanford University · 2023 - 2027

Dynamic imaging and tissue biomarker models to delineate indolent from aggressive breast calcifications

ResearchCo Investigator · Awarded by National Cancer Institute · 2022 - 2027

Building Interdisciplinary Research Careers in Women's Health - BIRCWH

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2002 - 2027

Human "Deep Learning": Can radiologists be trained to improve their interpretation and management of calcifications?

FellowshipMentor · Awarded by Association of University Radiologists Research and Education Foundation · 2024 - 2026

Comparing an Operation to Monitoring, with or without Endocrine Therapy (COMET), for low-risk ductal carcinoma in situ (DCIS)

ResearchPrincipal Investigator · Awarded by Breast Cancer Research Foundation · 2021 - 2025

Preoperative Breast Radiotherapy: A Tool to Provide Individualized and Biologically-Based Radiation Therapy

ResearchCollaborator · Awarded by Gateway for Cancer Research · 2015 - 2025

Point-of-care cellular and molecular pathology of breast tumors on a cell phone

ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2020 - 2025

NCI National Clinical Trials Network (UG1)

Clinical TrialCo-Principal Investigator · Awarded by National Institutes of Health · 2019 - 2025

Comparison of Operative to Medical Endocrine Therapy (COMET) for Low Risk DCIS

ResearchPrincipal Investigator · Awarded by Alliance for Clinical Trials in Oncology Foundation · 2016 - 2024

Defining the genomic clonal relationship between atypical breast lesions and metachronous invasive breast cancer

ResearchCollaborator · Awarded by Friends for an Earlier Breast Cancer Test · 2023 - 2024

Breast Pre-Cancer Atlas Center

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2018 - 2024

Regional Oncolytic Poliovirus Immunotherapy for Breast Cancer

ResearchCo Investigator · Awarded by Department of Defense · 2016 - 2024

A prospective, multi-center pivotal study of the LUM Imaging System for real-time, in vivo margin assessment in breast conserving surgery

ResearchPrincipal Investigator · Awarded by Massachusetts General Hospital · 2020 - 2024

Prevent Ductal Carcinoma in Situ Invasive Overtreatment Now - PRECISION

ResearchPrincipal Investigator · Awarded by MD Anderson Cancer Center · 2017 - 2024

Lumicell - PIVOTAL STUDY OF THE LUM IMAGING SYSTEM

Clinical TrialPrincipal Investigator · Awarded by Lumicell, Inc. · 2020 - 2023

Translational Research in Surgical Oncology

Inst. Training Prgm or CMECo-Principal Investigator · Awarded by National Institutes of Health · 2002 - 2022

Molecular and Radiologic Predictors of Invasion in a DCIS Active Surveillance Cohort

ResearchPrincipal Investigator · Awarded by Breast Cancer Research Foundation · 2020 - 2021

Genomic Diversity and the Microenvironment as Drivers of Progression in DCIS

ResearchPrincipal Investigator · Awarded by Department of Defense · 2014 - 2021

Comparing the Effectiveness of Guideline-concordant Care to Active Surveillance for DCIS: an Observational Study

ResearchPrincipal Investigator · Awarded by Patient-Centered Outcomes Research Institute · 2015 - 2021

Molecular and Radiologic Predictors of Invasion in a DCIS Active Surveillance Cohort

ResearchPrincipal Investigator · Awarded by Breast Cancer Research Foundation · 2019 - 2020

Targeting DAMP-induced inflammation to prevent metastasis

ResearchCo Investigator · Awarded by Department of Defense · 2016 - 2020

Molecular and Radiologic Predictors of Invasion in a DCIS Active Surveillance Cohort

ResearchPrincipal Investigator · Awarded by Breast Cancer Research Foundation · 2018 - 2019

Cancer Prevention Agent Development Program: Early Phase Clinical Research - CR

Clinical TrialPrincipal Investigator · Awarded by Northwestern University · 2016 - 2019

(PQC3) Genomic Diversity and the Microenvironment as Drivers of Metastasis in DCIS

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2014 - 2019

NCI National Clinical Trials Network U10 (Year 5)

Clinical TrialCo-Principal Investigator · Awarded by National Institutes of Health · 2014 - 2019

Genetic testing for women with high-risk breast lesions

ResearchCollaborating Investigator · Awarded by The Color Foundation · 2017 - 2018

Molecular and Radiologic Predictors of Invasion in a DCIS Active Surveillance Cohort

ResearchPrincipal Investigator · Awarded by Breast Cancer Research Foundation · 2016 - 2018

Cancer Prevention Agent Development Program: Early Phase Clinical Research - FP

Clinical TrialPrincipal Investigator · Awarded by Northwestern University · 2016 - 2018

Impact of the Oncotype DX DCIS Score on Treatment Decision Making in Patients with Ductal Carcinoma in Situ

ResearchPrincipal Investigator · Awarded by Genomic Health · 2013 - 2017

Optimizing Parameters and Techniques in Circulation Tumor Cell Collection (OPTICOLL)

Clinical TrialPrincipal Investigator · Awarded by University of Southern California · 2015 - 2017

Optimizing Parameters and Techniques in Circulation Tumor Cell Collection (OPTICOLL)

ResearchPrincipal Investigator · Awarded by Scripps Research Institute · 2013 - 2014

External Relationships


  • Clinetic
  • Merck
  • exai bio

This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.